
A new way to monitor glucose at home.
Join us in tackling one of the most urgent health challenges of our time – diabetes. We are on a mission to develop a groundbreaking product aimed at pre-diabetic populations. With millions estimated to be undiagnosed and at risk of developing Type 2 Diabetes, our innovative solution is poised to make a significant impact.
Through our product in development, we aim to provide accessibility and convenience, allowing individuals to perform a quick blood sugar test anytime, anywhere.
Be the first to receive exclusive updates on our latest developments.
Diabetes is a rapidly growing health concern worldwide, with millions of individuals at risk of developing the condition.
-
Prediabetes, a precursor to Type 2 Diabetes, often goes undetected, leading to a significant increase in healthcare costs and complications.
-
Despite its asymptomatic nature, without intervention, many individuals progress to Type 2 Diabetes within 3-5 years.
-
The financial burden on the healthcare system is staggering, with billions of dollars spent annually on Medicare expenditure for diabetes alone.
​
Smartest recognizes the urgent need for early detection and prevention tools to address this growing epidemic.


Introducing Smart-AE, our cutting-edge at-home blood glucose monitoring device.
​
Smart-AE is engineered to revolutionize blood glucose testing, making it easier, more convenient, and less invasive than ever before.
​
With its single-use disposable tests, integrated precision technology, and seamless connectivity to our mobile app, Smart-AE enables early detection of prediabetes and personalized interventions for improved health outcomes.
​
Early detection of high blood sugar levels can enable tailored diet and treatment plans, potentially preventing or delaying the onset of the disease for millions. Ensuring a better quality of life through simple and routine testing is at the heart of what we do.
About Us
With decades of combined experience spanning healthcare, engineering, and business, our diverse team is uniquely positioned to drive meaningful change in this field.

Ariel brings vast experience in business development, marketing and sales in the healthcare industry. He has managed large operations and teams in leading companies in the industry like Teva and Siemens. Ariel is experienced in managing millions of dollar business operations and holds a B.Sc. in Industrial Engineering and an MBA.
Ariel Horowitz
CEO

Eliezer is ex-8200, an experienced engineer with a versatile background, from data analysis to system engineering. He has vast knowledge of medical device R&D processes, including regulatory aspects. Eliezer is experienced in transfer to production of single-use medical devices. He holds a B.Sc. in Biomedical Engineering and is a graduate of the Biodesign Israel Program.
Eliezer Anavi
CTO

David has graduated from Tel Aviv University Medical School. He served as an OBGYN at Soroka Hospital, founded the Katovich Women’s Health Center, and was Chief Medical Officer at Ramat Aviv Medical Center for 18 years. He has also invested in and founded Versamed (sold to GE) and contributed to the founding of Dario Health (Nasdaq: Dario).
David Weintraub, MD
Founder
Contact Us
Are you an investor looking to support cutting-edge healthcare solutions? Or a collaborator interested in partnering with us to drive innovation? Join us in our mission to transform the landscape of diabetes management and prevention.
Phone
Social Media